Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contezolid Shortened Regimen for MAC Pulmonary Disease
NCT07213765Phase 4Recruiting
- Start
- Jul 2025
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of contezolid in mycobacterium avium complex pulmonary disease (MAC-PD). Started Jul 2025; status: recruiting.
02
Drugs
contezolid
03
Conditions
mycobacterium avium complex pulmonary disease (MAC-PD)
Beyond the preview
Go deeper on NCT07213765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07213765.